Actively Recruiting
Factors Associated with Urinary Incontinence and Evaluation of Pelvic Floor Muscle Activity in Patients with Multiple Sclerosis: Cross-Sectional Study
Led by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization · Updated on 2026-03-24
47
Participants Needed
1
Research Sites
5 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are examining the connection between urinary incontinence (UI) severity and pelvic floor muscle activity in women with multiple sclerosis (MS). This study also explores how UI relates to disability levels, fatigue, physical activity, and overall quality of life. Understanding these relationships aims to improve knowledge about UI in women with MS and guide future care approaches. The study involves observing pelvic floor muscle activity using surface electromyography (EMG) with biofeedback, conducted by trained physiotherapists. Participants will complete standardized questionnaires assessing urinary symptoms and their impact, physical activity, and fatigue. This cross-sectional study takes place at the Pelvic Floor Health Center, with each participant undergoing assessments lasting about 45 minutes. During the study, demographic and clinical details such as age, disease duration, MS type, and disability level (measured by the Expanded Disability Status Scale) will be collected. Researchers will measure pelvic floor muscle activity as the primary outcome and evaluate urinary symptoms, quality of life, physical activity, and fatigue as secondary outcomes. The study runs from March 2026 to October 2026 and includes women aged 30 to 50 years with MS and UI symptoms.
CONDITIONS
Brief Title
URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of multiple sclerosis according to the 2017 revised McDonald criteria
- Female patients aged 30 to 50 years
- Experiencing urinary incontinence symptoms per International Continence Society definition
- Expanded Disability Status Scale (EDSS) score below 6.5
- No communication difficulties
You will not qualify if you...
- MS patients who do not consent to participate
- MS patients with medication changes within the last 6 months
- Pregnant MS patients
- History of vaginal or cesarean delivery within the last 6 months
- Pelvic organ prolapse
- Urinary tract infection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single assessment lasting approximately 45 minutes
Participants complete questionnaires and pelvic floor muscle activity is evaluated using surface electromyography (EMG) with biofeedback by trained physiotherapists.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
Istanbul, Prof. Dr. Cemil Taşçıoğlu City Hospital, Turkey
Istanbul, Turkey (Türkiye)
Actively Recruiting
Research Team
B
Büşra Aydın Erkılıç, MSc
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here